Hosted on MSN23h
Shionogi’s Earnings Call: Growth Amidst Challenges
Shionogi & Co (($JP:4507)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Shionogi & Co.
Inhalon launches human challenge trial for RSV treatment
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
GlobalData on MSN6h
ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisation
The European Commission (EC) has authorised the use of ViiV Healthcare’s Vocabria (cabotegravir long-acting injections) plus ...